Using brain stimulation to treat depression in older adults
Official title: Transcranial Direct Current Stimulation for Depression
Run by Taipei Veterans General Hospital, Taiwan · NCT06187454 · Data updated 2026-11-12
This study is testing if a brain stimulation treatment can help older adults with depression who haven't found relief from regular medications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Taipei Veterans General Hospital, Taiwan Government |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | September 8, 2020 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 2, 2024 |
| Trial ID | NCT06187454 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly individuals diagnosed with major depression who have not benefited from antidepressant medications.
✕Probably not a fit
Patients with severe depression, a history of ineffectiveness with tDCS, or those with contraindications for the treatment will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the efficacy and safety of transcranial direct current stimulation (tDCS) as an additive treatment for elderly patients with late-life depression who have not responded to standard antidepressant therapy. Participants will receive either active tDCS or a sham treatment to assess improvements in depressive symptoms. The study aims to provide insights into the potential of tDCS as a safe and effective alternative for those who are resistant to or intolerant of traditional pharmacotherapy. The focus is on the prefrontal cortex, which is believed to play a crucial role in mood regulation.
Why it matters
Potential benefit: If successful, this approach could offer a new, non-invasive treatment option for elderly patients suffering from depression who do not respond to medications.
How similar studies have gone: Previous studies have shown promise for tDCS in treating depression, but this specific application in the elderly population is less explored and may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants who meet the criteria of major depression defined by DSM-5 criteria 2. Participants will be non-responders and taking an antidepressant of adequate dose and for ≥4 weeks in the current episode which has not led to sufficient clinical improvement (defined as a minimum level of 2 on the ATHF); or can't tolerate the adverse effects of antidepressant in the current episode 3. Ambulatory participants with or without any aiding device Exclusion Criteria: 1. An urgent risk of suicide or severe depression 2. A history of ineffectiveness with tDCS 3. People who are clinically contraindicated to receive tDCS intervention or MRI assessment, such as having any brain lesion, intracranial implants (clips, cochlear implants), a tattoo or metal embedded in their scalp or brain 4. Any instable medical condition 5. A history of epilepsy, 6. A history of substance use (within one year) 7. People with dementia or psychotic disorder. 8. Any condition which would make the subject unsuitable for the study under the physician's assessment.
Where it's running
-
TaipeiVGH
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Mu-N Liu, PhD
- Email: liumuen@gmail.com
- Phone: 0938595767
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
-
Mindfulness‑augmented brain stimulation for treatment‑resistant depression
This trial will test whether combining fast brain stimulation (iTBS) with a digital mindfulness program helps people with treatment‑resistant depression reduce symptoms and improve thinking.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.